Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 6
2018 4
2019 3
2020 7
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid Leukemia.
Mohanty S, Jyotsana N, Sharma A, Kloos A, Gabdoulline R, Othman B, Lai CK, Schottmann R, Mandhania M, Schmoellerl J, Grebien F, Ramsay E, Thomas A, Vornlocher HP, Ganser A, Thol F, Heuser M. Mohanty S, et al. Cancers (Basel). 2020 Sep 26;12(10):2766. doi: 10.3390/cancers12102766. Cancers (Basel). 2020. PMID: 32993115 Free PMC article.
IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis.
Kattih B, Shirvani A, Klement P, Garrido AM, Gabdoulline R, Liebich A, Brandes M, Chaturvedi A, Seeger T, Thol F, Göhring G, Schlegelberger B, Geffers R, John D, Bavendiek U, Bauersachs J, Ganser A, Heineke J, Heuser M. Kattih B, et al. Leukemia. 2021 May;35(5):1301-1316. doi: 10.1038/s41375-020-01043-x. Epub 2020 Sep 18. Leukemia. 2021. PMID: 32948843 Free PMC article.
Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia.
Kloos A, Mintzas K, Winckler L, Gabdoulline R, Alwie Y, Jyotsana N, Kattre N, Schottmann R, Scherr M, Gupta C, Adams FF, Schwarzer A, Heckl D, Schambach A, Imren S, Humphries RK, Ganser A, Thol F, Heuser M. Kloos A, et al. Leukemia. 2020 Nov;34(11):2951-2963. doi: 10.1038/s41375-020-0929-3. Epub 2020 Jun 24. Leukemia. 2020. PMID: 32576961 Free PMC article.
FLA-IDA salvage chemotherapy combined with a seven-day course of venetoclax (FLAVIDA) in patients with relapsed/refractory acute leukaemia.
Shahswar R, Beutel G, Klement P, Rehberg A, Gabdoulline R, Koenecke C, Markel D, Eggers H, Eder M, Stadler M, Hambach L, Ehrlich S, Göhring G, Schlegelberger B, Dammann E, Reuter M, Wichmann M, Neziri B, Ganser A, Thol F, Heuser M. Shahswar R, et al. Br J Haematol. 2020 Feb;188(3):e11-e15. doi: 10.1111/bjh.16268. Epub 2019 Nov 4. Br J Haematol. 2020. PMID: 31681986 Free PMC article. Clinical Trial. No abstract available.
Lipid nanoparticle-mediated siRNA delivery for safe targeting of human CML in vivo.
Jyotsana N, Sharma A, Chaturvedi A, Budida R, Scherr M, Kuchenbauer F, Lindner R, Noyan F, Sühs KW, Stangel M, Grote-Koska D, Brand K, Vornlocher HP, Eder M, Thol F, Ganser A, Humphries RK, Ramsay E, Cullis P, Heuser M. Jyotsana N, et al. Ann Hematol. 2019 Aug;98(8):1905-1918. doi: 10.1007/s00277-019-03713-y. Epub 2019 May 18. Ann Hematol. 2019. PMID: 31104089 Free PMC article.
Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Thol F, Gabdoulline R, Liebich A, Klement P, Schiller J, Kandziora C, Hambach L, Stadler M, Koenecke C, Flintrop M, Pankratz M, Wichmann M, Neziri B, Büttner K, Heida B, Klesse S, Chaturvedi A, Kloos A, Göhring G, Schlegelberger B, Gaidzik VI, Bullinger L, Fiedler W, Heim A, Hamwi I, Eder M, Krauter J, Schlenk RF, Paschka P, Döhner K, Döhner H, Ganser A, Heuser M. Thol F, et al. Blood. 2018 Oct 18;132(16):1703-1713. doi: 10.1182/blood-2018-02-829911. Epub 2018 Sep 6. Blood. 2018. PMID: 30190321 Free PMC article.
16 results